20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2298 | ML204 | TRP/TRPV Channel | |
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels. | |||
T7399 | LF3 | Wnt/beta-catenin | |
LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 (IC50 < 2 μM) | |||
T15633 | JW74 | Wnt/beta-catenin | |
JW74 antagonizes LiCl-induced activation of the canonical Wnt signaling (IC50: 420 nM). | |||
T4662 | SJ000291942 | TGF-beta/Smad | |
SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway. | |||
T8820 | BML-284 hydrochloride | BML-284 HCL,Wnt agonist 1 HCL | Wnt/beta-catenin |
BML-284 hydrochloride (Wnt agonist 1 HCL) is a potent, selective Wnt canonical signaling activator and tubulin polymerization inhibitor. | |||
T22884 | JW 67 | Wnt/beta-catenin | |
JW 67 is an inhibitor of canonical Wnt pathway signaling. JW 67 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1. | |||
T9263 | Cim0216 | N-(5-methyl-1,2-oxazol-3-yl)-2-phenyl-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide | TRP/TRPV Channel |
CIM0216 is a synthetic TRPM3 activator whose potency and apparent affinity greatly exceeds that of the canonical TRPM3 agonist. | |||
T16687 | Pyr3 | TRP/TRPV Channel | |
Pyr3 is a selective transient receptor potential canonical channel 3 inhibitor. Pyr3 inhibits TRPC3-mediated Ca2+ influx in a dose-dependent manner(IC50 = 700 nM). | |||
T8404 | Kasugamycin hydrochloride hydrate | Ksg (hydrochloride hydrate) | Antibacterial , Antibiotic |
Kasugamycin hydrochloride hydrate (Ksg (hydrochloride hydrate))(Ksg) specifically inhibits translation initiation of canonical but not of leaderless messenger RNAs. Ksg inhibition is thought to occur by direct competitio... | |||
TN7036 | N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide | (9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide,Macamide Impurity 14 | Wnt/beta-catenin |
N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide (Macamide Impurity 14) induces osteogenic differentiation and subsequent bone formation of mesenchymal stem cells by activating the canonical Wnt/β-catenin signaling pa... | |||
T12797 | RU-SKI 43 | RUSKI 43 | Hedgehog/Smoothened , Acyltransferase |
RU-SKI 43 is a potent and selective hedgehog acyltransferase (Hhat) inhibitor with an IC50 of 850 nM.RU-SKI 43 has anticancer activity and is a potential compound for the treatment of lung adenocarcinomas.RU-SKI 43 reduc... | |||
T3701 | MCC950 | CP-456773 | NOD |
CP-456773 (MCC950 (CP-456773) and CRID3) is an effective and specific cytokine release inhibitor and NLRP3 inflammasome inhibitor. CP-456773 inhibits IL-1β secretion and caspase 1 processing. MCC950 blocked canonical and... | |||
T15541 | Hyperforin dicyclohexylammonium salt | Hyperforin DCHA | Others |
Hyperforin dicyclohexylammonium salt is a transient receptor canonical 6 channel activator with antidepressant effect. It modulates Ca2+ levels by activating Ca2+-conducting non-selective canonical TRPC6 channels. | |||
T34271 | RBPI-3 | ||
RBPI-3 is a canonical poly(ADP-ribose) glycohydrolase. | |||
T13213 | TRPC6-IN-1 | Others | |
TRPC6-IN-1 is an inhibitor of the Transient Receptor Potential Canonical 6 Channel (TRPC6) (EC50: 4.66 μM). | |||
T72008 | E09241 | ||
E09241 is a novel OPG/RANKL upregulator, increasing OPG expression without affecting RANKL expression, promoting osteoblast differentiation while inhibiting osteoclast differentiation, regulating OPG expression through c... | |||
T60357 | NF-κB-IN-2 | JEUD-38 | |
NF-κB-IN-2 inhibits canonical NF-κB signaling induced by TNF-α in PC-3 cells. | |||
T75550 | Hyp9 | ||
Hyp9, a specific agonist for the transient receptor potential canonical 6 (TRPC6) channel, is utilized in spinal cord injury (SCI) research [1]. | |||
T69842 | DB2313 HCl | ||
DB2313 is a first-in-class potent small-molecule inhibitor of PU.1. DB2313 disrupts the interaction of PU.1 with target gene promoters and leads to down-regulation of canonical PU.1 transcriptional targets. | |||
T71147 | PBS-1086 | ||
PBS-1086 is a novel dual inhibitor of the canonical and noncanonical NF-κB pathways, increasing the magnitude and duration of initial EGFR inhibitor response in multiple NSCLC models, decreasing PDHK1 expression, and sup... |